RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients

被引:0
|
作者
Jörg-Christian Heinrich
Anne Tuukkanen
Michael Schroeder
Torsten Fahrig
Rudolf Fahrig
机构
[1] RESprotect,Biotec/Department of Computing
[2] Technical University Dresden,undefined
关键词
HSP27 (HSPB1); Chemotherapy; Chemoresistance; Molecular chaperones; Pancreatic cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1349 / 1361
页数:12
相关论文
共 37 条
  • [31] Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells
    Tokunaga, Masayuki
    Baron, Byron
    Kitagawa, Takao
    Tokuda, Kazuhiro
    Kuramitsu, Yasuhiro
    ANTICANCER RESEARCH, 2015, 35 (11) : 6063 - 6067
  • [32] A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers
    Chi, K. N.
    Yu, E. Y.
    Jacobs, C.
    Bazov, J.
    Kollmannsberger, C.
    Higano, C. S.
    Mukherjee, S. D.
    Gleave, M. E.
    Stewart, P. S.
    Hotte, S. J.
    ANNALS OF ONCOLOGY, 2016, 27 (06) : 1116 - 1122
  • [33] Forced Expression of Heat Shock Protein 27 (Hsp27) Reverses P-Glycoprotein (ABCB1)-mediated Drug Efflux and MDR1 Gene Expression in Adriamycin-resistant Human Breast Cancer Cells
    Kanagasabai, Ragu
    Krishnamurthy, Karthikeyan
    Druhan, Lawrence J.
    Ilangovan, Govindasamy
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (38) : 33289 - 33300
  • [34] Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells
    Matthias B. Stope
    Stefanie Peters
    Hannah Großebrummel
    Uwe Zimmermann
    Reinhard Walther
    Martin Burchardt
    World Journal of Urology, 2015, 33 : 323 - 327
  • [35] Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells
    Stope, Matthias B.
    Peters, Stefanie
    Grossebrummel, Hannah
    Zimmermann, Uwe
    Walther, Reinhard
    Burchardt, Martin
    WORLD JOURNAL OF UROLOGY, 2015, 33 (03) : 323 - 327
  • [36] Tumor Cell Expression of Heat Shock Protein (HSP) 72 is Influenced by HSP72 [HSPA1BA(1267)G] Polymorphism and Predicts Survival in Small Cell Lung Cancer (SCLC) Patients
    Szondy, Klara
    Rusai, Krisztina
    Szabo, Attila J.
    Nagy, Andrea
    Gal, Krisztina
    Fekete, Andrea
    Kovats, Zsuzsanna
    Losonczy, Gyorgy
    Lukacsovits, Jozsef
    Mueller, Veronika
    CANCER INVESTIGATION, 2012, 30 (04) : 317 - 322
  • [37] Baseline circulating tumor cells (CTC) and serum heat shock protein 27 (Hsp27) levels are increased in advanced bladder cancer (BC) patients with poor prognostic factors: Results from the randomized phase 2 Borealis-1™ trial of first-line gemcitabine/cisplatin plus apatorsen or placebo
    Petrylak, D.
    Eigl, B.
    Senkus, E.
    Loriot, Y.
    Twardowski, P.
    Castellano, D.
    Blais, N.
    Sridhar, S.
    Sternberg, C.
    Retz, M.
    Blumenstein, B.
    Jacobs, C.
    Stewart, P.
    Bellmunt, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S525 - S525